Gary Black says Tesla Inc. (NASDAQ:TSLA) will capitalize on the growing EV adoption among drivers, as well as increasing demand for self-driving vehicles. What Happened: Quoting a post on social media platform X, which asked Black's views on Elon Musk's EV giant's current trajectory, he shared his thoughts on Thursday. "TSLA's more affordable car strategy seems deja vu 2023-2024 – price cuts funded by cost cuts with no volume growth," he said as Tesla is offering cheaper variants of its models in the U.S. He added that the Austin robotaxi launch in June held an "asymmetrical risk/return." Don’t Miss: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — don't repeat history — invest in RYSE at just $1.90/share. Nancy Pelosi Invested $5 Million In An AI Company Last Year — Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000. However, the investor also shared that he was optimistic about the company's future. "Long term we like the $TSLA story." He said before adding, "As EV adoption and demand for autonomy increases, $TSLA remains the best positioned to capitalize on these two megatrends," Why It Matters: Tesla has been teasing the arrival of its Robotaxi in June, with CEO Musk confirming that there would at least be 10-20 Model Y robotaxis in Austin on launch day. Tesla has also rolled out its robotaxi in limited runs restricted to employees in cities like Austin and San Francisco, where it has clocked more than 15,000 miles and 1,500 trips. Elsewhere, the company has touted its self-driving capabilities with Musk expressing optimism in the brand's FSD (Full Self-Driving) tech and went as far as to say that manually driven cars will become obsolete in the future. However, Musk's robotaxi ambitions are grappling with hurdles as the USPTO or U.S. Patent and Trademark Office refused to grant the company trademarks for the terms "Robotaxi" as well as "Cybercab." Story Continues Read Next: Invest where it hurts — and help millions heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold. Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.30/share! Photo Courtesy: Trygve Finkelsen on Shutterstock.com Send To MSN: Send to MSN Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Tesla Bull Gary Black Reaffirms Elon Musk's Company 'Best Positioned To Capitalize' On EVs And Autonomous Driving, But There's A Catch originally appeared on Benzinga.com © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments
Tesla Bull Gary Black Reaffirms Elon Musk's Company 'Best Positioned To Capitalize' On EVs And Autonomous Driving, But There's A Catch
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...